Mitral valve surgery in non-ischemic cardiomyopathy

Journal of Cardiovascular Surgery

Volumn 45, Issue 5, 2004, Pages 477-486

  Ngaage, D L ^a   Schaff, H V ^a  

^a Mayo Clinic   (United States)

Author keywords

Heart valve diseases; Mitral valve, surgery; Myocardial diseases

Indexed keywords

CARDIOVASCULAR RISK; CELL TRANSPLANTATION; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MORTALITY; NEUROENDOCRINE SYSTEM; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; PLASTIC SURGERY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRESSURE GRADIENT; REVIEW; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL RATE; SYSTEMATIC REVIEW; THROMBOEMBOLISM; THROMBOGENESIS; TREATMENT INDICATION; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

CARDIAC SURGICAL PROCEDURES; CARDIOMYOPATHY, DILATED; COMORBIDITY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MITRAL VALVE INSUFFICIENCY; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 11344278192     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-6.
2. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997;133:703-12.
3. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993;22(4 Suppl A):6A-13A.
4. Cowie MR, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Suresh V et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J 1999;20:421-8.
5. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996;93:841-2.
6. Sangiorgi M. Clinical and epidemiological aspects of cardiomyopathies: a critical review of current knowledge. Eur J Intern Med 2003;14:5-17.
7. Adams KF Jr, Zannad F. Clinical definition and epidemiology of advanced heart failure. Am Heart J 1998; 135(6 Pt 2 Su):S204-15.
8. Baig MK, Mahon N, McKenna WJ, Caforio AL, Bonow RO, Francis GS et al. The pathophysiology of advanced heart failure. Am Heart J 1998;135(6 Pt 2 Su):S216-30.
9. Keeling PJ, Gang Y, Smith G, Seo H, Bent SE, Murday V et al. Familial dilated cardiomyopathy in the United Kingdom. Br Heart J 1995;73:417-21.
10. Ortiz-Lopez R, Li H, Su J, Goytia V, Towbin JA. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation 1997;95:2434-40.
11. Maeda M, Holder E, Lowes B, Valent S, Bies RD. Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin. Circulation 1997;95:17-20.
12. Borow KM, Neumann A, Wynne J. Sensitivity of end-systolic pressure-dimension and pressure-volume relations to the inotropic state in humans. Circulation 1982;65:988-97.
13. Rector TS, Olivari MT, Levine TB, Francis GS, Cohn JN. Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. Am Heart J 1987;114(1 Pt 1):148-52.
14. Packer M. New concepts in the pathophysiology of heart failure: beneficial and deleterious interaction of endogenous haemodynamic and neurohormonal mechanisms. J Intern Med 1996;239:327-33.
15. Burnett JC Jr, Kao PC, Hu DC, Heser DW, Heublein D, Granger JP et al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986;231:1145-7.
16. Raine AE, Erne P, Burgisser E, Muller FB, Bolli P, Burkart F et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 1986;315:533-7.
17. Rodeheffer RJ. Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004? J Am Coll Cardiol 2004;44:740-9.
18. Abassi Z, Karram T, Ellaham S, Winaver J, Hoffman A. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Pharmacol Ther 2004;102:223-41.
19. Di Napoli P, Taccardi AA, Grilli A, Felaco M, Balbone A, Angelucci D et al. Left ventricular wall stress as a direct correlate of cardiomyocyte apoptosis in patients with severe dilated cardiomyopathy. Am Heart J 2003;146:1105-11.
20. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994;331:1564-75.
21. Bansch D, Bocker D, Brunn J, Weber M, Breithardt G, Block M. Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators. J Am Coll Cardiol 2000;36:566-73.
22. Falk RH, Foster E, Coats MH. Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study. Am Heart J 1992;123:136-42.
23. Pulerwitz T, Rabbani LE, Pinney SP. A rationale for the use of anticoagulation in heart failure management. J Thromb Thrombolysis 2004;17:87-93.
24. D'Cruz IA, Shroff SG, Janicki JS, Jain A, Reddy HK, Lakier JB. Differences in the shape of the normal, cardiomyopathic, and volume overloaded human left ventricle. J Am Soc Echocardiogr 1989;2:408-14.
25. Perloff JK, Roberts WC. The mitral apparatus. Functional anatomy of mitral regurgitation. Circulation 1972;46:227-39.
26. Otsuji Y, Handschumacher MD, Schwammenthal E, Jiang L, Song JK, Guerrero JL et al. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation 1997;96:1999-2008.
27. Kono T, Sabbah HN, Rosman H, Alam M, Jafri S, Goldstein S. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 1992;20:1594-8.
28. Hueb AC, Jatene FB, Moreira LF, Pomerantzeff PM, Kallas E, de Oliveira SA. Ventricular remodeling and mitral valve modifications in dilated cardiomyopathy: new insights from anatomic study. J Thorac Cardiovasc Surg 2002;124:1216-24.
29. Kwan J, Shiota T, Agler DA, Popovic ZB, Qin JX, Gillinov MA et al. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study. Circulation 2003;107:1135-40.
30. Otsuji Y, Kumanohoso T, Yoshifuku S, Matsukida K, Koriyama C, Kisanuki A et al. Isolated annular dilation does not usually cause important functional mitral regurgitation: comparison between patients with lone atrial fibrillation and those with idiopathic or ischemic cardiomyopathy. J Am Coll Cardiol 2002;39:1651-6.
31. Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation 2000;102:1400-6.
32. Juilliere Y, Marie PY, Danchin N, Gillet C, Paille F, Karcher G et al. Radionuclide assessment of regional differences in left ventricular wall motion and myocardial perfusion in idiopathic dilated cardiomyopathy. Eur Heart J 1993;14:1163-9.
33. Yamaguchi S, Tsuiki K, Hayasaka M, Yasui S. Segmental wall motion abnormalities in dilated cardiomyopathy: hemodynamic characteristics and comparison with thallium-201 myocardial scintigraphy. Am Heart J 1987;113:1123-8.
34. Dent JM, Spotnitz WD, Nolan SP, Jayaweera AR, Glasheen WP, Kaul S. Mechanism of mitral leaflet excursion. Am J Physiol 1995;269(6 Pt 2):H2100-8.
35. Tsakiris AG, Gordon DA, Padiyar R, Frechette D. Relation of mitral valve opening and closure to left atrial and ventricular pressures in the intact dog. Am J Physiol 1978;234:H146-51.
36. Hung J, Otsuji Y, Handschumacher MD, Schwammenthal E, Levine RA. Mechanism of dynamic regurgitant orifice area variation in functional mitral regurgitation: physiologic insights from the proximal flow convergence technique. J Am Coll Cardiol 1999;33:538-45.
37. Patel JB, Borgeson DD, Barnes ME, Rihal CS, Daly RC, Redfield MM. Mitral regurgitation in patients with advanced systolic heart failure. J Card Fail 2004;10:285-91.
38. Blondheim DS, Jacobs LE, Kotler MN, Costacurta GA, Parry WR. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 1991;122(3 Pt 1):763-71.
39. Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002;144:524-9.
40. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759-64.
41. Fujimoto S, Parker KH, Gibson DG. Right ventricular filling in dilated cardiomyopathy. Br Heart J 1995;74:287-92.
42. Juilliere Y, Buffet P, Marie PY, Berder V, Danchin N, Cherrier F. Comparison of right ventricular systolic function in idiopathic dilated cardiomyopathy and healed anterior wall myocardial infarction associated with atherosclerotic coronary artery disease. Am J Cardiol 1994;73:588-90.
43. Juilliere Y, Barbier G, Feldmann L, Grentzinger A, Danchin N, Cherrier F. Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. Eur Heart J 1997;18:276-80.
44. Lewis JF, Webber JD, Sutton LL, Chesoni S, Curry CL. Discordance in degree of right and left ventricular dilation in patients with dilated cardiomyopathy: recognition and clinical implications. J Am Coll Cardiol 1993;21:649-54.
45. Abramson SV, Burke JF, Kelly JJ Jr, Kitchen JG 3rd, Dougherty MJ, Yih DF et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 1992;116:888-95.
46. Calafiore AM, Gallina S, Contini M, Iaco A, Barsotti A, Gaeta F et al. Surgical treatment of dilated cardiomyopathy with conventional techniques. Eur J Cardiothorac Surg 1999;16 Suppl 1:S73-8.
47. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991;325:293-302.
48. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987;316:1429-35.
49. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8.
50. Plank DM, Yatani A, Ritsu H, Witt S, Glascock B, Lalli MJ et al. Calcium dynamics in the failing heart: restoration by beta-adrenergic receptor blockade. Am J Physiol Heart Circ Physiol 2003;285:H305-15.
51. Szalay ZA, Civelek A, Hohe S, Brunner-LaRocca HP, Klovekorn WP, Knez I et al. Mitral annuloplasty in patients with ischemic versus dilated cardiomyopathy. Eur J Cardiothorac Surg 2003; 23:567-72.
52. Calafiore AM, Gallina S, Di Mauro M, Gaeta F, Iaco AL, D'Alessandro S et al. Mitral valve procedure in dilated cardiomyopathy: repair or replacement? Ann Thorac Surg 2001;71:1146-52; discussion 52-3.
53. Bolling SF, Deeb GM, Brunsting LA, Bach DS. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg 1995;109:676-82; discussion 82-3.
54. Goldman ME, Mora F, Guarino T, Fuster V, Mindich BP. Mitral valvuloplasty is superior to valve replacement for preservation of left ventricular function: an intraoperative two-dimensional echocardiographic study. J Am Coll Cardiol 1987;10:568-75.
55. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 1995;91:1022-8.
56. David TE, Komeda M, Pollick C, Burns RJ. Mitral valve annuloplasty: the effect of the type on left ventricular function. Ann Thorac Surg 1989;47:524-7; discussion 7-8.
57. Timek TA, Dagum P, Lai DT, Liang D, Daughters GT, Ingels NB Jr et al. Pathogenesis of mitral regurgitation in tachycardia-induced cardiomyopathy. Circulation 2001;104(12 Suppl 1):I47-53.
58. Radovanovic N, Mihajlovic B, Selestiansky J, Torbica V, Mijatov M, Popov M et al. Reductive annuloplasty of double orifices in patients with primary dilated cardiomyopathy. Ann Thorac Surg 2002;73:751-5.
59. Calafiore AM, Di Mauro M, Gallina S, Canosa C, Iaco AL. Optimal length of pericardial strip for posterior mitral overreductive annuloplasty. Ann Thorac Surg 2003;75:1982-4.
60. Bolling SF. Mitral reconstruction in cardiomyopathy. J Heart Valve Dis 2002;11 Suppl 1:S26-31.
61. Odell JA, Schaff HV, Orszulak TA. Early results of a simplified method of mitral valve annuloplasty. Circulation 1995;92(9 Suppl):II150-4.
62. Calafiore AM, Mauro MD, Gallina S, Yassin IM, Shaheen YA, Canosa C et al. Surgical treatment of mitral valve regurgitation in dilated cardiomyopathy. Heart Surg Forum 2004;7:21-5.
63. Koch CG, Milas BL, Savino JS. What does transesophageal echocardiography add to valvular heart surgery? Anesthesiol Clin North Am 2003;21:587-611.
64. Johnson ML, Holmes JH, Spangler RD, Paton BC. Usefulness of echocardiography in patients undergoing mitral valve surgery. J Thorac Cardiovasc Surg 1972;64:922-34.
65. Click RL, Abel MD, Schaff HV. Intraoperative transesophageal echocardiography: 5-year prospective review of impact on surgical management. Mayo Clin Proc 2000;75:241-7.
66. McCarthy PM, Starling RC, Young JB, Smedira NG, Goormastic M, Buda T. Left ventricular reduction surgery with mitral valve repair. J Heart Lung Transplant 2000;19(8 Suppl):S64-7.
67. Suma H, Isomura T, Horii T, Sato T, Kikuchi N, Iwahashi K et al. Two-year experience of the Batista operation for non-ischemic cardiomyopathy. J Cardiol 1998;32:269-76.
68. Isomura T, Suma H, Horii T, Sato T, Kikuchi N, Iwahashi K. The Batista operation in patients with dilated cardiomyopathy. J Card Surg 1999;14:124-8.
69. Buffolo E, Paula IA, Palma H, Branco JN. A new surgical approach for treating dilated cardiomyopathy with mitral regurgitation. Arq Bras Cardiol 2000;74:129-40.
70. Batista RJ, Verde J, Nery P, Bocchino L, Takeshita N, Bhayana JN et al. Partial left ventriculectomy to treat end-stage heart disease. Ann Thorac Surg 1997;64:634-8.
71. Nair RU, Williams SG, Nwafor KU, Hall AS, Tan LB. Left ventricular volume reduction without ventriculectomy. Ann Thorac Surg 2001;71:2046-9.
72. Chachques JC, Grandjean P, Nataf P, Mihaileanu S, Perier P, Bourgeois I et al. Dynamic cardiomyoplasty: a surgical approach for ventricular assistance. Int J Artif Organs 1988;11:469-74.
73. Aklog L, Murphy MP, Chen FY, Smith WJ, Laurence RG, Appleyard RF et al. Right latissimus dorsi cardiomyoplasty improves left ventricular function by increasing peak systolic elastance (Emax). Circulation 1994;90(5 Pt 2):II112-9.
74. Chachques JC, Marino JP, Lajos P, Zegdi R, D'Attellis N, Fornes P et al. Dynamic cardiomyoplasty: clinical follow-up at 12 years. Eur J Cardiothorac Surg 1997;12:560-7; discussion 7-8.
75. Moreira LF, Benicio A, Bacal F, Bocchi EA, Stolf NA, Oliveira SA. Determinants of long-term mortality of current palliative surgical treatment for dilated cardiomyopathy. Eur J Cardiothorac Surg 2003;23:756-63; discussion 63-4.
76. Hung J, Koelling T, Semigran MJ, Dec GW, Levine RA, Di Salvo TG. Usefulness of echocardiographic determined tricuspid regurgitation in predicting event-free survival in severe heart failure secondary to idiopathic-dilated cardiomyopathy or to ischemic cardiomyopathy. Am J Cardiol 1998;82:1301-3, A10.
77. Takarada A, Kurogane H, Hayashi T, Fujimoto T, Yasaka Y, Fukumoto Y et al. Prognostic significance of atrial fibrillation in dilated cardiomyopathy. Jpn Heart J 1993;34:749-58.
78. Handa N, Schaff HV, Morris JJ, Anderson BJ, Kopecky SL, Enriquez-Sarano M. Outcome of valve repair and the Cox maze procedure for mitral regurgitation and associated atrial fibrillation. J Thorac Cardiovasc Surg 1999;118:628-35.
79. Triposkiadis F, Pitsavos C, Boudoulas H, Trikas A, Toutouzas P. Left atrial myopathy in idiopathic dilated cardiomyopathy. Am Heart J 1994;128:308-15.
80. Chen. Mitral valve repair in cardiomyopathy. Circulation 1998;98(19 Suppl):II124-7.
81. Badhwar V, Bolling SF. Mitral valve surgery in the patient with left ventricular dysfunction. Semin Thorac Cardiovasc Surg 2002;14:133-6.
82. Gummert JF, Rahmel A, Bucerius J, Onnasch J, Doll N, Walther T et al. Mitral valve repair in patients with end stage cardiomyopathy: who benefits? Eur J Cardiothorac Surg 2003;23:1017-22; discussion 22.
83. Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998;115:381-6; discussion 7-8.
84. Romano MA, Bolling SF. Mitral valve repair as an alternative treatment for heart failure patients. Heart Fail Monit 2003;4:7-12.
85. Enriquez-Sarano M, Schaff HV, Orszulak TA, Bailey KR, Tajik AJ, Frye RL. Congestive heart failure after surgical correction of mitral regurgitation. A long-term study. Circulation 1995;92:2496-503.